BSD Medical’s China Distributor Purchases BSD-2000 Hyperthermia System

SALT LAKE CITY--(BUSINESS WIRE)--BSD Medical Corporation (NASDAQ:BSDM) (the “Company” or “BSD”) announced today that Dalian Orientech Co. Ltd (“Orientech”), the Company’s exclusive China distributor, has purchased a BSD-2000 Hyperthermia System (BSD-2000). The Company recently announced the renewal of the distributorship agreement with Orientech and this is the first of several BSD-2000 orders per year required under the 4-year contract with Orientech. Orientech has placed a significant number of BSD-2000 Hyperthermia Systems in leading hospitals in China, including a recent installation at Jiamusi Tumour Hospital, a premier oncology hospital in China. The BSD-2000 System utilizes BSD’s proprietary synchronous phased array technology to non-invasively target therapeutic heating (hyperthermia) to certain cancerous tumors, including those located deep within the body. Studies have shown that hyperthermia treatment can kill cancer cells directly as well as increase the effectiveness of other cancer therapies, including radiation therapy, for the treatment of certain tumors.

MORE ON THIS TOPIC